Toll-like receptors play essential roles in the modulation of melanogenesis, which has been implicated in the pathogenesis of hyper-or hypopigmentation-related diseases. However, little is currently known regarding the role of TLR9 in human melanocytes. TLR9 recognizes unmethylated cytosine-phosphate-guanine motif-containing oligodeoxynucleotides, and cytosine-phosphate-guanine ODN2006 acts as an hTLR9 agonist. The aim of the present study was to investigate the effect of cytosine-phosphate-guanine ODN2006 on melanogenesis in the human melanocyte cells. MTT assay and enzyme-linked immunosorbent assay indicated that ODN2006 stimulation (0, 1, 5, 10 mM) dose-dependently reduced cell viability and promoted the production of TNF-a, IL-6, and IL-8 in PIG1 melanocytes. The mRNA and protein levels of PMEL and TYRosinase were elevated at 6 h, and then decreased 24 h later, but were significantly augmented 72 h later following ODN2006 stimulation; whereas, TLR9 expressions were time-dependently increased in PIG1 melanocytes. Moreover, ultraviolet B irradiation combined with ODN2006 stimulation induced much more significant enhancement of PMEL, TYRosinase, and TLR9 mRNA and protein after three days in PIG1 melanocytes, and the similar results were obtained using the primary human melanocytes. The expression of TLR9 protein was down-regulated by TLR9 siRNA transfection. ODN2006 had an additive effect on ultraviolet B-induced melanogenesis and PMEL expression, as well as NF-kB activation, which could be blocked by TLR9 knockdown, the NF-kB specific inhibitor PDTC, or the TBK1 inhibitor BX795. Collectively, we concluded that TLR9 regulates melanogenesis through NF-kB activation, suggesting that TLR9 may play a role in microbial-induced melanogenesis.
Introduction
Chronic dermatological conditions often give rise to abnormal skin pigmentation. Skin pigment-related diseases, including melanoma, vitiligo, and seborrheic keratosis (SK) are often associated with excessive or reduced production of melanin. 1 Epidermal melanocytes synthesize melanin pigments from TYRosine (TYR) and accumulate melanin in specialized cellular organelles called melanosomes, which are transported from melanocytes to adjacent keratinocytes. 2, 3 Melanogenesis is the process of producing the melanin pigment, and involves a series of chemical and enzymatic pathways. 4 Hence, modulation of this process may become an important approach in the treatment of hyper-or hypopigmentation-related diseases.
Human melanocytes are not simply professional pigment-producing cells, but also have the phagocytic capacity and produce pro-inflammatory mediators. Toll-like receptors (TLRs) have been implicated in both innate host defense against pathogens and inflammatory response. Research has also shown that TLRs activation in melanocytes may play a role in the modulation of melanogenesis. 5 However, the mechanisms of recognition of microbes by TLRs in melanocytes have not yet been fully explored.
Among the TLR family members, TLR9 is primarily expressed on antigen-presenting cells and is one of a group of intracellular receptors located in endosomal compartments that are responsible for the recognition of nucleic acids derived from viruses, bacteria, and the host. TLR9 recognized non-methylated cytosine-phosphate-guanine (CpG) motifs in bacterial or viral DNA as foreign, thus playing an essential role in the specific cellular response to CpG DNA. 6 Un-methylated CpG motifs are considered to be pathogen-associated molecular patterns (PAMPs) due to their abundance in microbial genomes but scarcity in vertebrate genomes. 7 The activation of TLR9 by microbial DNA or synthetic oligonucleotides is based on these motifs, leading to the induction of innate immune responses. In the specific cellular response to CpG DNA, TLR9 À/À mice are completely unresponsive to CpG DNA, whereas TLR9 þ/þ , TLR2 b/À , and TLR4 À/À mice respond normally to CpG DNA. 8, 9 Additionally, TLR9 has been indicated to play an important role in detecting and combatting viral infections. 10 Accordingly, we speculated that TLR9 signaling may participate in the process of melanogenesis in human melanocytes.
Melanocytes can produce substances with a range of biological functions including antimicrobial defense. Meanwhile, TLRs play an important role in the cellular response through the recognition of pathogens. Currently, unmethylated CpG motif-containing oligodeoxynucleotides (ODNs) have been well characterized as agonists of TLR9. The sequence of ODN2006 is a CpG ODN that acts as an hTLR9 agonist and is used as the basic CpG ODN material. Here, we evaluated the stimulatory effects of the TLR9 agonist ODN2006 on melanogenesis in human melanocyte cell line PIG1, as a possible therapeutic agent to address hypopigmentation disorders.
Materials and methods

Cell culture and cell treatment
The immortalized human melanocyte cell line PIG1 was a gift from Professor Caroline Le Poole 11 from the Department of Dermatology, University of Cincinnati, USA. Normal primary human melanocytes were isolated from teenaged epidermal foreskin and cultured according to the normal method. 11 Cells were cultured in 254 medium supplemented with 5% fetal calf serum (FCS) and human melanocyte growth supplement (S-002-5) at 37 C in a humidified atmosphere with 5% CO 2 . The 254 medium, FCS, and S-002-5 were all purchased from Gibco BRL (Gaithersburg, MD, USA). In the following assays, after serum starvation for 24 h, cells were preconditioned with 25 mM pyrrolidine dithiocarbamate (PDTC) or 5 mM BX795 (both from Sigma, St. Louis, MO, USA) for 1 h prior to ODN2006 stimulation (Invitrogen, Carlsbad, CA, USA) and ultraviolet B (UVB) irradiation as indicated for three days.
Immunofluorescence microscopy
Cultured PIG1 melanocytes (3 Â 10 5 ) were plated onto a glass coverslip. After overnight incubation, cells were washed twice with PBS and fixed with methanol at À20 C for 15 min, followed by two further washes with PBS. Coverslips were incubated in blocking buffer containing the appropriate primary antibodies at 4 C for 1 h, and then washed for four times with PBS. The primary antibodies were rabbit anti-premelanosome protein (PMEL) polyclonal Ab, rabbit anti-TYRosinase (TYR) polyclonal Ab, and mouse anti-TLR9 monoclonal Ab (Abcam, Cambridge, MA, USA). Fluorescein isothiocyanate (FITC)-conjugated goat anti-rabbit immunoglobulin G (IgG) (Molecular Probes, Eugene, OR) and FITC-conjugated rabbit anti-mouse IgG (Invitrogen, Carlsbad, CA, USA) were used as secondary antibodies. At the final step, the cells were incubated with 1 mg/mL fluorescent dye DAPI (Sigma, Saint Louis, MO, USA) for 30 min to evaluate the position of nucleus. Images of treated cells were captured using an Olympus FluoView FV1000 confocal laser scanning microscope (Olympus, Tokyo, Japan) and analyzed with Olympus FV1000 software FV10-ASW version 2.1 b.
UVB irradiation
UVB radiation was performed using a modification of a previously published protocol. 12 In brief, PIG1 melanocytes were cultured in six-well plates and washed once with PBS. Cells were then covered with 1 mL PBS and exposed to UVB (wavelength 296-298 nm) at 20 mJ/cm 2 for three days. The UVB was emitted by SS-01B-2 UV phototherapy equipment (Shanghai Sigma High Technology Co., LTD, Shanghai, China) with a light intensity of 11.2 mW/cm 2 . Immediately after radiation, the PBS was replaced with 2 mL fresh complete medium, and cells were further cultured for a period before being harvested. Cells were divided into four groups to examine the effects of ODN2006 and UVB: control group, ODN2006-treated group (5 mM for three days), UVB-irradiated group (20 mJ/cm 2 once daily for three days), and ODN2006 þ UVB-treated group [treated with UVB (20 mJ/cm 2 once daily for 3 days) following pretreatment with ODN2006].
MTT assay
PIG1 melanocytes (5 Â 10 3 ) were plated into 96-well plates (Corning Inc., Corning, NY, USA) and incubated overnight. After serum starvation for 24 h, cells were stimulated with ODN2006 (1, 5, 10 mM; Invitrogen, Carlsbad, CA, USA) at 37 C in 5% of CO 2 . After 72 h, 20 mL of modified tetrazolium salt 3 -(4,5-dimethyl-2-thiazolyl)-2,5-dipheny-2H-tetrazolium-bromide (MTT, 5 mg/mL; Sigma, Saint Louis, MO, USA) was added to each well and samples were incubated at 37 C for 4 h. Then, the supernatant was carefully removed and 100 mL of DMSO (Sigma, Saint Louis, MO, USA) was added to lyse the cells. Once the dark-blue MTT crystals had dissolved, the absorbance was measured at 490 nm using a Benchmark microplate reader (Bio-Rad, Hercules, CA, USA).
Enzyme-linked immunosorbent assay PIG1 melanocytes (4 Â 10 5 ) were plated into six-well plates (Corning Inc.) and incubated overnight. After serum starvation for 24 h, cells were cultured in the presence of different concentrations of ODN2006 (1, 5, 10 mM) at 37 C in 5% of CO 2 . After stimulation for 72 h, culture supernatants were harvested. Cytokines, including TNF-a, IL-6, and IL-8, contained in the conditioned medium were analyzed in triplicate using sandwich-type ELISA kits (R&D Systems, Minneapolis, MN, USA) according to the manufacturer's instructions. The absorbance at 450 nm was determined using a microplate reader.
Real-time reverse transcription-polymerase chain reaction (RT-PCR)
PIG1 melanocytes (4 Â 10 5 ) were plated into six-well plates and cultured overnight. After serum starvation for 24 h, cells were treated as indicated. The total RNA was purified using the RNeasy Mini kit (Qiagen, German) according to the manufacturer's instructions. For real-time reverse transcription-polymerase chain reaction (RT-PCR) analyses, 1 mg of DNase-treated total RNA was reverse transcribed. The amplification of the cDNA was accomplished using the ABI Prism 7900HT sequence detection system (Applied Biosystems) in the presence of the commercially available SYBR Green PCR Master Mix (Takara) in a 40-cycle PCR. The denaturing, annealing, and extension conditions of each PCR cycle were 95 C for 5 s, 60 C for 20 s and 72 C for 34 s, respectively. The relative expression was calculated using the 2 ÀÁÁCt method. The mRNA expression levels were normalized to the levels of b-actin and represented as fold induction. The primer sequences of PMEL, TYR, TLR9, and b-actin used in this RT-PCR analysis are shown in Table 1 and were synthesized by Sangon Biotech Co., Ltd. (Shanghai, China).
Melanin content determination
After serum starvation for 24 h, cells were treated as indicated. The total amount of melanin was measured using the sodium hydroxide solubilization method. 13 Briefly, the harvested cells were dissolved in 1 mL of 1 N NaOH at 100 C for 30 min and centrifuged for 20 min at 16,000 g. The optical densities of the supernatants were measured at 400 nm using an ELISA reader. The absorbance was compared with a standard curve of synthetic melanin (Sigma, St. Louis, MO, USA).
siRNA transfection
For siRNA transfection, PIG1 melanocytes (4 Â 10 5 ) were seeded in six-well plates, grown overnight, and transfected on the following day with TLR9-siRNA (50 nM; GenePharma, Shanghai, China) or the non-silencing control siRNA (si-NS, 50 nM; GenePharma, Shanghai, China), as indicated using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA), according to the manufacturer's instructions.
The knockdown efficiency was verified 48 to 72 h after transfection.
Western blot analysis
Cell lysates were collected and protein concentrations were determined using the Pierce BCA Protein Assay Kit (Thermo Scientific, Rockford, IL, USA). Equal amounts of protein were processed for Western blotting following the standard protocols. The primary antibodies used were rabbit anti-PMEL monoclonal Ab, rabbit anti-TYR polyclonal Ab, mouse anti-TLR9 monoclonal Ab, and rabbit anti-b-actin polyclonal Ab (dilution, 1:1000; Abcam, Cambridge, MA, USA), and rabbit anti-NF-kB p65 polyclonal Ab (dilution, 1:1000; Santa Cruz Biotechnology, Santa Cruz, CA, USA). After incubation with proper secondary antibodies linked to horseradish peroxidase (HRP), the resultant protein bands were visualized by ECL (Beyotime, Shanghai, China). The absorbance values of the target proteins were calculated using Gel-Pro Analyzer version 4.0 software (Media Cybernetics, Silver Spring, MD, USA) and normalized to b-actin for quantification analysis.
Statistical analysis
Data are expressed as mean AE standard deviation of results derived from three individual experiments performed in triplicate. All analyses were conducted using SPSS software (SPSS Inc., Chicago, IL, USA). Statistical analysis was performed using Student's t-test and analysis of variance. *P < 0.05 was considered to indicate a statistically significant difference.
Results
ODN2006 reduced cell viability and promoted pro-inflammatory cytokine production in PIG1 melanocytes
Using the MTT assay, we found that ODN2006 stimulation (1, 5, 10 mM) reduced the cell viability of PIG1 melanocytes in a dose-dependent manner. After 72 h incubation, the viability of cells exposed to 1 mM ODN2006 showed little change. A slight decrease of 14% was induced by 5 mM ODN2006, while 10 mM ODN2006 led to a notable 47% reduction in cell viability in PIG1 melanocytes (Figure 1(a) ). In addition, ELISA demonstrated that ODN2006 incubation (1, 5, 10 mM) enhanced the levels of TNF-a, IL-6, and IL-8 in a dose-dependent manner in PIG1 melanocytes (Figure 1(b) ). Thus, 5 mM was chosen as the optimal ODN2006 dose for subsequent assays.
ODN2006 regulated the expression of PMEL, TYR, and TLR9 in PIG1 melanocytes
The results indicated that ODN2006 stimulation clearly regulated the expression of PMEL, TYR, and TLR9 to different degrees as indicated by real-time RT-PCR and Western blotting in PIG1 melanocytes. The mRNA and protein levels of PMEL and TYR were increased after 6 h, and then decreased 24 h later, but significantly augmented 72 h 
ODN2006 had an additive effect on UVB-induced expression of PMEL, TYR, and TLR9 in human melanocytes
Real-time RT-PCR and Western blotting analyses showed that the expression levels of PMEL, TYR, and TLR9 mRNA and protein were also obviously elevated after UVB irradiation for three days, and this was reinforced by ODN2006 stimulation in PIG1 melanocytes (Figure 3(a) and (c)). The similar results were obtained using the primary human melanocytes in this study (Figure 3(b) and (d) ).
Hence, we concluded that ODN2006 stimulation could regulate the expression of PMEL, TYR, and TLR9 by strengthening the action of UVB irradiation in human melanocytes.
ODN2006 stimulation enhanced melanogenesis via TLR9/NF-iB signaling in PIG1 melanocytes
Compared with the control group, ODN2006 stimulation and UVB irradiation induced a significant increase in melanin content. Compared with the TLR9 NS siRNA group, the expression of TLR9 protein was down-regulated by TLR9 siRNA transfection (Figure 4(a) ). Compared with the UVB-irradiated group, the ODN2006 þ UVB-treated group showed a much more significant increase in melanin content, suggesting that ODN2006 treatment had an additive effect on UVB-induced melanin synthesis (Figure 4(b) ).
To elucidate the intracellular signaling pathways involved in ODN2006-and UVB-induced melanogenesis, we analyzed NF-kB signaling in human melanocytes treated with ODN2006 and UVB irradiation. Western blot analysis revealed that the expression of NF-kB p65 was significantly up-regulated in the ODN2006-treated group and UVBtreated group, and was even higher in the (Figure 4(c) ). The increase in melanin content and the expression of NF-kB p65 and PMEL caused by ODN2006 stimulation and UVB irradiation were alleviated by TLR9 siRNA transfection and NF-kB-specific inhibitor PDTC, as well as TANK-binding kinase 1 (TBK1) inhibitor BX795 pretreatment, respectively (Figure 4(d) and (e)).
Discussion
Several studies suggest that TLRs play essential roles in the pathogenesis of melanogenesis. Among them, TLR9 is specific for unmethylated CpG ODNs that are present in bacterial DNA, and the short synthetic single-stranded CpG ODNs can induce the Th1-type immune response through interaction with TLR9. But whether TLR9 is involved in the pathogenic process of melanogenesis and further, the related cellular mechanisms are still not well understood.
In this study, we treated the human melanocytes PIG1 with ODN2006 and UVB to evaluate the role of TLR9 signaling in melanin biosynthesis. The involvement of TLRs in inflammatory disorders has been related to numerous cutaneous infections. 14, 15 Environmental factors such as UV irradiation and dermatological conditions such as atopic dermatitis, psoriasis, and other autoimmune disorders can affect cytokine levels in human skin tissues. 16, 17 Cytokines and related inflammatory mediators directly or indirectly regulate the proliferation and rate of melanogenesis in human epidermal melanocytes. 18 TLR9 activation induces the production of IL-6 and TNFa in response to ODN2006. 19, 20 In addition, CpG-ODN 2006 elevates the production of chemokines and inflammatory cytokines in a dose-dependent manner, 21 and CpG-ODNs can suppress the proliferation of A549 lung adenocarcinoma cells via TLR9 signaling. 22 Consistently, our results showed that ODN2006 enhanced the levels of TNF-a, IL-6, and IL-8 in PIG1 melanocytes and also led to a notable reduction in cell viability. Therefore, abnormal inflammatory responses and loss of cell viability may underlie the pathological process of melanogenesis in response to ODN2006.
Skin pigment plays a critical role in protecting the organism. It is well known that synthesis and transfer of melanin are pivotal in the study of pigmentary skin diseases. UV irradiation can directly induce melanogenesis in several types of cultured melanocytes and promote skin pigmentation in mouse. 23, 24 Melanogenic enzyme TYR regulates melanin synthesis and catalyzes the rate-limiting step of melanogenesis. 25 In addition, the melanosome is a specialized membrane-surrounded organelle that is involved in the synthesis, storage, and transport of melanin. PMEL (also called Pmel17, gp100, and silver) in humans is a 668-amino acid type I transmembrane melanosome-specific structural glycoprotein, 26 which initiates pre-melanosome morphogenesis within multivesicular bodies and thus directly involves in the biogenesis of premelanosomes. 27 Figure 3 Effects of ODN2006 stimulation and UVB irradiation on the mRNA and protein expression levels of PMEL, TYR, and TLR9 in human melanocytes. (a, c) After serum starvation for 24 h, PIG1 melanocytes were treated with UVB (20 mJ/cm 2 once daily) following pretreatment with ODN2006 for three days, and then subjected to respective detection. The mRNA and protein expression levels of PMEL, TYR, and TLR9 were evaluated using real-time RT-PCR and Western blotting, respectively. (b, d) After serum starvation for 24 h, the primary human melanocytes were treated with UVB (20 mJ/cm 2 once daily) following pretreatment with ODN2006 for three days, and then subjected to respective detection. The mRNA and protein expression levels of PMEL, TYR, and TLR9 were evaluated using real-time RT-PCR and Western blotting, respectively
Real-time RT-PCR and Western blot analyses showed that the expression of PMEL and TYR was elevated at 6 h, and then decreased 24 h later, but was significantly augmented 72 h later following ODN2006 stimulation. This variation in the expression of PMEL was, to some extent, consistent with that of TYR, which is known to be regulated by UVB. 24, 28 Research has shown that inhibition of UVB-induced melanogenesis and TYR expression was associated with enhanced levels of ubiquitination-dependent proteolysis. 29 UVB-induced TYR-related protein 2 (TRP-2) expression plays an important role along with TYR in melanogenesis, and TRP-2 down-regulation could be inhibited by ubiquitination inhibitor MG-132 through proteasomal degradation. 30 Therefore, we speculated that the downregulation of PMEL and TYR proteins 24 h after UVB was involved in ubiquitination-dependent proteolysis.
As the first line of the innate immune system, the skin plays a crucial role in defense against cutaneous microbial infection. Despite evidence for the existence of TLRs in melanocytes, little is currently known regarding the role of TLR9 in human melanocytes. TLRs recognize specific PAMPs and subsequently trigger innate immunity. Figure 4 Effects of ODN2006 stimulation and UVB irradiation on melanin synthesis and TLR9/NF-kB signaling pathway in PIG1 melanocytes. After serum starvation for 24 h, PIG1 melanocytes transfected with or without TLR9-siRNA/TLR9-siNS were preconditioned with 25 mM PDTC or 5 mM BX795 for 1 h, and then treated with ODN2006 followed by UVB treatment (20 mJ/cm 2 once daily) for three days, and then subjected to respective detection. (a, c, e) The expression of TLR9, NF-kB p65, PMEL, and b-actin proteins was evaluated using Western blotting. (b, d) Melanin content was determined by measuring the absorbance at 400 nm. The sodium hydroxide solubilization method was used to determine the melanin content CpG motifs, immunostimulatory components of bacterial DNA, can activate innate immunity through TLR9, 31 and are thought to have potential for various immune therapies such as for cancer, asthma, pollinosis, and infectious diseases. CpG ODN2006 stimulation directly activates TLR9 in human tonsillar B cells. 20 In our study, ODN2006 stimulation enhanced TLR9 expression in a time-dependent manner. Compared with the UVB-induced increase in PMEL/TYR/melanin, much more significant increase in PMEL/TYR/melanin associated with prominent NF-kB activation was shown in the UVB þ ODN2006-treated group. This finding demonstrated that ODN2006 has an additive effect on UVB-induced melanogenesis via PMEL and TYR elevation, as well as significant NF-kB activation.
Moreover, CpG ODN 2006 promotes the activation of p65-NF-kB and MAPK signaling pathways in L02 hepatocytes in a dose-dependent manner. 21 The NF-kB-specific inhibitor PDTC reduces the effects induced by ODN2006 in a study on hemocytic immune responses. 32 TBK1, a member of IkB Kinase (IKK)-related kinases in the activation of NF-kB pathway, plays a role in regulating innate immunity and inflammation. BX795 inhibits NF-kB signaling and arrests cell proliferation in oral cancer cells. 33 We found that the increase in PMEL/melanin and NF-kB p65 activation was induced by ODN2006 stimulation and UVB irradiation, and these effects were distinctly reduced by TLR9 knockdown, PDTC pretreatment, or TBK1 inhibitor BX795 pretreatment, respectively. These results support the notion that the impairment of physiological TLR9/NF-kB signaling may be able to neutralize or negate the enhancing effect of ODN2006 on PMEL/melanin expression.
Collectively, we demonstrated that the expression of PMEL, TYR, and TLR9 could be regulated by ODN2006 stimulation. ODN2006 stimulated inflammatory responses and reduced cell viability, and further, had an additive effect on UVB-induced melanogenesis associated with NF-kB activation. These results suggest that TLR9 may play a role in microbial-induced melanogenesis through NF-kB signaling.
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